Recommended

Paraplegia After Intercostal Neurolysis

New Targets In Breast Cancer

Prognostic Significance Of Cdh13 Hypermethylati...

Dietary Habits And Relation To Cancer Disease I...

Peer Observers And Quality Of Cancer Mdt Meetings

0 votes
Robotic Radical Cystectomy In Bladder Cancer
Author: Abdullah Erdem Canda, Ali Fuat Atmaca, Muhammed Ersagun Arslan, Murat Keske, Ozer Ural Cakici, Serdar Cakmak, Davut Kamaci, Emre Urer
Publisher: MARTÍN SÁNCHEZ BERTA
11 pages
One time payment: €0.00
Required subscription: Free
Type of publication: Article
ISBN/ISSN: 1178-7082
DOI: 10.2147/42290
Follow this publisher

Share this publication:

Description:

Abstract: Open radical cystectomy (RC) is the gold standard surgical approach in the management of muscle invasive bladder cancer in addition to high-grade, recurrent, noninvasive tumors. With the development of surgical robotic technology, robotic-assisted laparoscopic radical cystectomy (RARC) is increasingly being performed as a minimally invasive surgical approach. A learning curve exists with a recommended case number of at least 20 RARC procedures in order to achieve satisfying outcomes in terms of operation time, complication rate, and oncological outcomes, including positive surgical margins (SMs) and lymph node (LN) yield. In the current literature, long-term outcomes of RARC are not yet available. Due to the outcomes of the published literature, RARC seems to have satisfactory oncologic and functional outcomes in addition to acceptable complication rates. Intraoperative blood loss and transfusion rates seem to be decreased in RARC series when compared to open approaches. On the other hand, a number of authors have reported decreased complication rates but increased operation time in the robotic approach. Similar oncologic results including positive SM rates and LN yields were detected in most comparative publications. Totally intracorporeal RARC with urinary diversion is a complex procedure and the number of centers performing this type of surgery is currently very limited. Although, it is still too early to make strict conclusions about RARC, RARC with intracorporeal urinary diversion has the potential to be the future of robotic bladder cancer surgery. Therefore, further prospective and randomized studies with increased numbers of patients and with longer follow-up are needed. Lastly, RARC may be related to increased cost when compared to open surgery, although controversial reports exist about this issue.

Select a payment method